Inventor
HOLMES MICHAEL C
US64 patents
⚠️ This page may combine multiple inventors who share the name “HOLMES MICHAEL C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANGAMO BIOSCIENCES INC
27 patentsUS7914796B2Mar 29, 2011
Engineered cleavage half-domains
SANGAMO BIOSCIENCES INC221 citations99
US7888121B2Feb 15, 2011
Methods and compositions for targeted cleavage and recombination
SANGAMO BIOSCIENCES INC355 citations99
US9616090B2Apr 11, 2017
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
SANGAMO BIOSCIENCES INC51 citations98
US9597357B2Mar 21, 2017
T cell modifying compounds and uses thereof
SANGAMO BIOSCIENCES INC111 citations98
US7951925B2May 31, 2011
Methods and compositions for gene inactivation
SANGAMO BIOSCIENCES INC213 citations98
US9782437B2Oct 10, 2017
Methods and compositions for targeted cleavage and recombination
SANGAMO BIOSCIENCES INC18 citations93
US9434776B2Sep 6, 2016
Methods and compositions for gene inactivation
SANGAMO BIOSCIENCES INC26 citations93
US9937207B2Apr 10, 2018
Targeted disruption of T cell receptor genes using talens
SANGAMO BIOSCIENCES INC37 citations92
US9222105B2Dec 29, 2015
Methods and compositions for modification of the HPRT locus
SANGAMO BIOSCIENCES INC16 citations92
US10072062B2Sep 11, 2018
Methods and compositions for modification of a HLA locus
SANGAMO BIOSCIENCES INC11 citations84
US9957526B2May 1, 2018
Delivery methods and compositions for nuclease-mediated genome engineering
SANGAMO BIOSCIENCES INC14 citations84
US9260726B2Feb 16, 2016
Targeted integration and expression on exogenous nucleic acid sequences
SANGAMO BIOSCIENCES INC7 citations84
US8895264B2Nov 25, 2014
Methods and compositions for modification of the HPRT locus
SANGAMO BIOSCIENCES INC10 citations84
US10046028B2Aug 14, 2018
Methods and compositions for modulating PD1
SANGAMO BIOSCIENCES INC7 citations83
US9629930B2Apr 25, 2017
Methods and compositions for treating hemophilia B
SANGAMO BIOSCIENCES INC8 citations82
US10604771B2Mar 31, 2020
Delivery methods and compositions for nuclease-mediated genome engineering
SANGAMO BIOSCIENCES INC7 citations76
US10907175B2Feb 2, 2021
Isolated human cell with an inactivated glucocorticoid receptor gene
SANGAMO BIOSCIENCES INC2 citations73
US9963715B2May 8, 2018
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC3 citations73
US9765360B2Sep 19, 2017
Linear donor constructs for targeted integration
SANGAMO BIOSCIENCES INC2 citations73
US9752140B2Sep 5, 2017
Methods and compostions for targeted genomic deletion
SANGAMO BIOSCIENCES INC3 citations73
US9717759B2Aug 1, 2017
Modification of CXCR4 using engineered zinc finger proteins
SANGAMO BIOSCIENCES INC2 citations73
US9650648B2May 16, 2017
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC4 citations73
US9574211B2Feb 21, 2017
Methods and compositions for prevention or treatment of a disease
SANGAMO BIOSCIENCES INC4 citations73
US10155011B2Dec 18, 2018
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
SANGAMO BIOSCIENCES INC4 citations72
US10117899B2Nov 6, 2018
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
SANGAMO BIOSCIENCES INC2 citations72
US9115409B2Aug 25, 2015
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
SANGAMO BIOSCIENCES INC4 citations72
US9376685B2Jun 28, 2016
Linear donor constructs for targeted integration
SANGAMO BIOSCIENCES INC2 citations63
SANGAMO THERAPEUTICS INC
6 patentsUS9833479B2Dec 5, 2017
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
SANGAMO THERAPEUTICS INC5 citations84
US11311574B2Apr 26, 2022
Methods and compositions for targeted cleavage and recombination
SANGAMO THERAPEUTICS INC0 citations63
US11236175B2Feb 1, 2022
T cell modifying compounds and uses thereof
SANGAMO THERAPEUTICS INC0 citations63
US11884930B2Jan 30, 2024
Method of inactivating a glucocorticoid receptor gene in an isolated cell
SANGAMO THERAPEUTICS INC0 citations62
US11591622B2Feb 28, 2023
Method of making and using mammalian liver cells for treating hemophilia or lysosomal storage disorder
SANGAMO THERAPEUTICS INC0 citations62
US11492643B2Nov 8, 2022
Methods and compositions for treatment of a genetic condition
SANGAMO THERAPEUTICS INC0 citations62
GREGORY PHILIP D
4 patentsUS8563314B2Oct 22, 2013
Methods and compositions for modulating PD1
GREGORY PHILIP D86 citations96
US9567573B2Feb 14, 2017
Genome editing of a Rosa locus using nucleases
GREGORY PHILIP D10 citations84
US9175280B2Nov 3, 2015
Methods and compositions for treating hemophilia B
GREGORY PHILIP D9 citations82
US9834787B2Dec 5, 2017
Targeted integration into stem cells
GREGORY PHILIP D5 citations68
HOLMES MICHAEL C
4 patentsUS9566352B2Feb 14, 2017
Methods and compositions for inhibiting viral entry into cells
HOLMES MICHAEL C22 citations93
US8871905B2Oct 28, 2014
Modification of CXCR4 using engineered zinc finger proteins
HOLMES MICHAEL C9 citations83
US9121072B2Sep 1, 2015
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
HOLMES MICHAEL C5 citations82
US8936936B2Jan 20, 2015
Methods and compositions for targeted integration
HOLMES MICHAEL C12 citations80
ANDO DALE
2 patentsCOLLINGWOOD TREVOR
1 patentDEKELVER RUSSELL
1 patentBONINI MARIA CHIARA
1 patentGUSCHIN DMITRY
1 patentCUI XIAOXIA
1 patentURNOV FYODOR
1 patentGUSCHIN DMITRY M
1 patentShowing the top 50 of 64 patents by PatentIndex Score.